Other competencies
- Conducting clinical studies in radiation oncology (head of the study secretariat)
- Academic teaching for the subject of radiation oncology (Certificate in Didactics in Medicine)
- MR-Linac based treatment of head and neck tumors
- Stereotactic radiotherapy
- Combination of radiotherapy with chemotherapy or antibody therapy
- Treatment and research into HPV-associated malignancies
Career
| 2023 | Titular Professor in Radio-Oncology, University of Zurich, CH |
| Since 01/2021 | Senior Attending Physician, Clinic for Radio-Oncology, USZ, CH |
| Since 01/2019 | Clinical lead of the Radiation Oncology department at USZ – CIRCLE |
| Since 01/2019 | Lead of the Radiation Oncology study office |
| 10/2018 – 12/2020 | Senior Physician meV, Clinic for Radio-Oncology, USZ, CH |
| 01/2015 – 09/2018 | Staff member, SAPHIR radiosurgery – Cyberknife, Schleusenweg 2, Frankfurt, D |
| 11/2013 – 09/2018 | Consultant and Faculty member, Department of Radiotherapy, J.W. Goethe University Frankfurt, D |
| 2016 | Habilitation Privatdozent in Radiation Oncology, J.W. Goethe University Frankfurt (title: „Radiotherapy for Squamous Cell Carcinoma of the Head and Neck: Biology and Treatment Optimization for Primary and Recurrent Disease“ |
| 07/2008 – 10/2013 | Resident in Radiation Oncology, Department of Radiotherapy, J.W. Goethe University Frankfurt, D |
| 2010 | Doctoral Degree, J.W. Goethe University, Frankfurt, D (Prof. Dr. Bergmann, Onkology |
| 10/2001 – 06/2008 | Medical studies, J.W. Goethe University Frankfurt, Germany |
Most important memberships
- European Organization for Research and Treatment of Cancer (EORTC)
- European Society of Radiation Oncology (ESTRO)
- Swiss Society of Radiation Oncology (SSRO)
- Swiss Group for Clinical Cancer Research (SAKK)
- German Society of Radiation Oncology (DEGRO)
- Swiss Head and Neck Society (SHNS)
- German Consortium for Translational Cancer Research (DKTK) – RadOnc group
- European Head and Neck Society (EHNS)
- European Academy for Tumor Immunology (EATI)
- German Cancer Society (DKG) and Study
- Group Radiation Oncology (ARO)
Research focus
- Head and neck tumors: clinical multimodal treatment, translational radiation oncology, development of new radiation and planning techniques (MR-Linac, automatic target volume definition)
- Treatment and biology of HPV-associated malignancies
- Immunology in head and neck and anal carcinomas
Publications
Show publication listFurther
Journal Editorial Board Member
- Scientific Reports
- Frontiers in Oncology: section head and neck tumors
- PloS One
- Cancers
- Radiotherapy and oncology
Participation in Guidelines
- S2k-guideline basal cell carcinoma (2018, update 2024)
- ESMO-guidelines for treatment of head and neck cancer during the COVID-19 pandemic (2020)
- ASTRO-ESTRO recommendations for head and neck radiotherapy during the COVID-19 pandemic (2020)
- German S3-guideline for diagnosis and treatment of oro- and hypopharyngeal cancer (2024)
- Ongoing Swiss Guideline for diagnosis and treatment of Malignant Melanoma (kick off 10/2022)
Q-Award USZ 2020: for the project interdisciplinary “fast track” intake for patients with head and neck cancer; Cancer League brochure “Esophageal cancer”, 2021 Investigator in clinical trials (selection) SUPPORTAN (2008-2011) – Phase III, randomized, multicentric trial BEVXELOX-RT (2008-2009) – Phase II, single-arm, multicentric trial PACCIS-RT (2010-2015) – Phase IV, randomized, multicentric trial POLYPROBE (2011) – translational research, multicentric trial INVERT headneck (2013) – Phase IV, single-arm, single-centre trial DÖSAK-pN1 from 2009 – Phase III, randomized, multicentric trial SOCCER (2013 -2016) multicentric, observation trial HNprädBio (2013- 2018) – translational research, multicentric trial CONKO-007 (2013-2018) – Phase III, randomized, multicentric trial HYPOSIB (2016-2018) – Phase III, randomized, multicentric trial HYPOSTAT (2016-2018) – Phase II, single-arm, multicentric trial MARTHA (2019- ongoing) – Phase II, single-arm, unicentric trial DOSIS-RCT (2019-ongoing) – Phase III, randomized, multicentric trial IOSI-RTO-001 (2019-ongoing) – Phase II, single-arm, multicentric trial RADIANCE (2020-ongoing) – Phase II, randomized, multicentric trial CHECKMATE 73L (2021-ongoing) – Phase III, radnomized, multicentric trial EORTC-1945-OLIGORARE (2021-ongoing) – Phase III, randomized, multicentric trial SABR-COMET-10 (2021-ongoing) – Phase III, randomized, multicentric trial XRAY VISION (2023-ongoing) – Phase III, randomized, multicentric trial PROTECT (2023-ongoing) – Phase III, randomized, multicentric trial